LizarBio Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

LizarBio General Information

Description

Developer of a cell-based therapy designed to treat heart failure and Rett syndrome. The company's therapy is used to produce cardiac cells to treat people with congestive heart failure problems, specifically ischemic heart failure, enabling pharmaceutical companies to apply these developments in regenerative medicine, either personalized medicine or cell therapy and organ development.

Contact Information

Formerly Known As
PluriCell Biotech
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Cietec - Sala 229, Avenida Professor Lineu Prestes
  • 2242 - Butantã
  • Sao Paulo, 05508-000
  • Brazil
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Cietec - Sala 229, Avenida Professor Lineu Prestes
  • 2242 - Butantã
  • Sao Paulo, 05508-000
  • Brazil

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LizarBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Jan-2024 Completed Out of Business
9. Later Stage VC (Series A) 30-Apr-2021 Completed Pre-Clinical Trials
8. Seed Round 15-Apr-2022 Completed Pre-Clinical Trials
7. Accelerator/Incubator 26-Feb-2021 Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-Jan-2020 Completed Pre-Clinical Trials
5. Later Stage VC 22-May-2019 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2019 Completed Startup
3. Seed Round 01-Apr-2016 Completed Startup
2. Accelerator/Incubator 01-Jan-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view LizarBio’s complete valuation and funding history, request access »

LizarBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LizarBio FAQs

  • When was LizarBio founded?

    LizarBio was founded in 2013.

  • Where is LizarBio headquartered?

    LizarBio is headquartered in Sao Paulo, Brazil.

  • What is the size of LizarBio?

    LizarBio has 7 total employees.

  • What industry is LizarBio in?

    LizarBio’s primary industry is Drug Discovery.

  • Is LizarBio a private or public company?

    LizarBio is a Private company.

  • What is LizarBio’s current revenue?

    The current revenue for LizarBio is .

  • How much funding has LizarBio raised over time?

    LizarBio has raised $8.23M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process